Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
106.96
(
-0.14%
)
Bitcoin
78,468.01
(
-0.09%
)
News Focus
News Focus
Post# of 257485
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 176009

Wednesday, 03/26/2014 3:47:51 PM

Wednesday, March 26, 2014 3:47:51 PM

Post# of 257485
Sunitinib was approved for 2nd line GIST (it was very close to your threshold in 1st line as well) based on reported HR (95% CI) of 0.33 and the primary endpoint was time-to-progression (TTP).
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today